Novavax aims for name recognition in new vaccines campaign
After suffering delay after delay, Novavax finally made it to the FDA back in January with its protein-based Covid-19 vaccine. But the Maryland-based company isn’t waiting for an authorization to get its name out there.
Novavax launched two unbranded marketing campaigns on Thursday encouraging Americans to roll up their sleeves and get vaccinated. The ‘We Do Vaccines’ program, aimed at consumers, features information about common types of vaccines, including the “well-established” protein-based vaccines Novavax is working on. There’s also information about the clinical trial process and vaccine safety.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
